Profil
Daniel Getts is the founder of Cour Pharmaceuticals Development Co., Inc.,CREATE Medicines, Inc. (Massachusetts).
Dr. Getts is currently Director at Curate Biosciences since 2022.
Formerly, Dr. Getts was Director-Research & Development at Tolera Therapeutics, Inc. and Vice President-Research at TCR² Therapeutics, Inc. from 2017 to 2019.
Dr. Getts earned a doctorate from Northwestern University and both a graduate degree and a doctorate from The University of Sydney.
Postes actifs de Daniel Getts
| Sociétés | Poste | Début |
|---|---|---|
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Fondateur | - |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Directeur/Membre du Conseil | 15/08/2022 |
Anciens postes connus de Daniel Getts
| Sociétés | Poste | Fin |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 01/03/2019 |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Fondateur | - |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Corporate Officer/Principal | - |
Formation de Daniel Getts
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Commercial Services |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Commercial Services |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
















